Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03128255
Other study ID # I-124-04/2017
Secondary ID
Status Recruiting
Phase N/A
First received April 20, 2017
Last updated May 3, 2017
Start date April 26, 2017
Est. completion date April 2018

Study information

Verified date April 2017
Source Jena University Hospital
Contact Martin Freesmeyer, Dr.med.
Phone +49 3641 9-329805
Email martin.freesmeyer@med.uni-jena.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Regular thyroid diagnostics versus augmented thyroid work-up with additional I-124 PET/US fusion for metabolic-sonographic nodule allocation in patients with benign thyroid diseases


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date April 2018
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients with thyroidal nodules,

- euthyroidism

- Uptake >0,5% on Tc-99m-pertechnetate- scintigraphy

Exclusion Criteria:

- thyroid medications in the last 6 months

- Iodine exposition in the last 6 months

- thyroid surgery or radioiodine therapy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Assessment of already preacquired I-124 PET/US
Assessment of preacquired I-124 PET/US by review of anonymous digital case files

Locations

Country Name City State
Germany University Hospital Jena Jena Thuringia

Sponsors (2)

Lead Sponsor Collaborator
Jena University Hospital GE Healthcare

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Metabolic-sonographic nodule allocation The number of correct assignments of metabolic function of each nodule will be assessed for each group seperately. A three-point scale will be used for evaluation of the nodule's function and the degree of the physicians certainty will be investigated using a four-point scale. 1 year
See also
  Status Clinical Trial Phase
Terminated NCT04614389 - Utility of Contrast-Enhanced Sonography and Shear Wave Elastography N/A
Recruiting NCT03295955 - Comparing Efficacy of Postoperative Oral Antibiotic Use in Trans-Oral Thyroidectomy N/A
Completed NCT04647006 - Comparison of TOETVA and Conventional Thyroidectomy N/A
Not yet recruiting NCT06029946 - B-mode Ultrasound, Sono-Elastography, and Diffusion-weighted Imaging MRI in Thyroid Nodules
Recruiting NCT05025046 - NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
Terminated NCT01320813 - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy N/A
Completed NCT00877630 - Minimal Invasiveness of Endoscopic Thyroidectomy N/A
Completed NCT01964508 - microRNA in Thyroid Cancer
Completed NCT06306599 - Ultrasound Operator Influence on Diagnostics With AI for Thyroid Nodules - Clinial Trial N/A
Recruiting NCT04730726 - In Vivo Multispectral Optoacoustic Imaging of Thyroid Nodules N/A
Not yet recruiting NCT03884140 - Clinical Diagnostic Approach for Cases of Thyroid Nodules
Completed NCT04277455 - Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules N/A
Recruiting NCT02225509 - Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology N/A
Completed NCT00552253 - Levothyroxine Treatment in Thyroid Benign Nodular Goiter N/A
Not yet recruiting NCT03700762 - Application of Ultrasonic Gray-scale Ratio in Differentiating Benign From Malignant Thyroid Nodules.
Enrolling by invitation NCT01757834 - Shear Wave Ultrasound Elastography in Noninvasive Diagnosis of Thyroid Nodules N/A
Completed NCT01292044 - The Role of Elastography in the Diagnosis of Thyroid Nodules N/A
Completed NCT00858104 - Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results Phase 4
Completed NCT00651625 - Reciprocating Medical Devices - a Study of a New Safety Device N/A
Completed NCT05132478 - The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer N/A